BioPharma Credit Statistics
Total Valuation
BOPCF has a market cap or net worth of 987.03 million. The enterprise value is 981.41 million.
| Market Cap | 987.03M |
| Enterprise Value | 981.41M |
Important Dates
The next estimated earnings date is Wednesday, September 24, 2025.
| Earnings Date | Sep 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.13B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -6.65% |
| Shares Change (QoQ) | -3.81% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 993.65M |
Valuation Ratios
The trailing PE ratio is 8.08.
| PE Ratio | 8.08 |
| Forward PE | n/a |
| PS Ratio | 6.58 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 8.82 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 8.03 |
| EV / Sales | 6.54 |
| EV / EBITDA | n/a |
| EV / EBIT | 8.03 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09
| Current Ratio | 2.09 |
| Quick Ratio | 2.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.69% and return on invested capital (ROIC) is 6.05%.
| Return on Equity (ROE) | 9.69% |
| Return on Assets (ROA) | 5.97% |
| Return on Invested Capital (ROIC) | 6.05% |
| Return on Capital Employed (ROCE) | 10.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.80% in the last 52 weeks. The beta is 0.10, so BOPCF's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +6.80% |
| 50-Day Moving Average | 0.84 |
| 200-Day Moving Average | 0.85 |
| Relative Strength Index (RSI) | 33.95 |
| Average Volume (20 Days) | 184,029 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOPCF had revenue of 150.03 million and earned 122.18 million in profits. Earnings per share was 0.10.
| Revenue | 150.03M |
| Gross Profit | 150.03M |
| Operating Income | 122.18M |
| Pretax Income | 122.18M |
| Net Income | 122.18M |
| EBITDA | n/a |
| EBIT | 122.18M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 5.62 million in cash and n/a in debt, giving a net cash position of 5.62 million.
| Cash & Cash Equivalents | 5.62M |
| Total Debt | n/a |
| Net Cash | 5.62M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.18B |
| Book Value Per Share | 1.00 |
| Working Capital | 19.53M |
Cash Flow
| Operating Cash Flow | 111.91M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 81.44% and 81.44%.
| Gross Margin | 100.00% |
| Operating Margin | 81.44% |
| Pretax Margin | 81.44% |
| Profit Margin | 81.44% |
| EBITDA Margin | n/a |
| EBIT Margin | 81.44% |
| FCF Margin | n/a |
Dividends & Yields
BOPCF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 89.23% |
| Buyback Yield | 6.65% |
| Shareholder Yield | n/a |
| Earnings Yield | 12.38% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BOPCF has an Altman Z-Score of 37.35.
| Altman Z-Score | 37.35 |
| Piotroski F-Score | n/a |